MedTrace Logo

Thiamine Supplementation to Improve Cardiac Function in Patients With Congestive Heart Failure

NCT00770107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-06-27

No results posted yet for this study

Summary

Working Hypothesis: a treatment with thiamine improves functional status and heart function of patients with congestive heart failure when on a diuretic treatment.

Conditions

Interventions

DRUG

Thiamine

Supplementation of thiamine (vitamin b1) 300 mg per day, once daily, for a duration of 4 weeks

DRUG

Placebo

Placebo, once daily, for a duration of 4 weeks

Sponsors & Collaborators

  • Luzerner Kantonsspital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00770107 on ClinicalTrials.gov